Sympathomimetics in nasal allergy

Area of Science:

• Allergy and Immunology
• Pharmacology
• Otorhinolaryngology

Background:

• Allergic rhinitis frequently causes significant nasal congestion and airway obstruction.
• Current treatments may not fully address mucosal congestion symptoms.

Purpose of the Study:

• To evaluate the efficacy of a topical alpha-adrenoceptor agonist, phenylpropanolamine, in managing allergic rhinitis symptoms.
• To assess the impact on nasal airway resistance and congestion.

Main Methods:

• A placebo-controlled, double-blind, crossover study was conducted.
• 10 subjects with allergic rhinitis underwent nasal allergen challenge.
• Nasal airway resistance was measured using anterior rhinomanometry; symptoms (blockage, secretion, sneezes) were scored.

Main Results:

• Topical phenylpropanolamine significantly reduced nasal airway resistance.
• The degree of nasal blockage was also significantly decreased.
• Symptom scores indicated a reduction in congestion.

Conclusions:

• Topical alpha-adrenoceptor agonists demonstrate potential for symptomatic relief in allergic rhinitis.
• Phenylpropanolamine may be an effective treatment for mucosal congestion in allergic rhinitis.